Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2025)

Treace Medical Concepts' Income from Continuing Operations history spans 6 years, with the latest figure at 6745000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 989.66% year-over-year to 6745000.0; the TTM value through Dec 2025 reached 56697000.0, down 1.12%, while the annual FY2025 figure was 56697000.0, 1.12% down from the prior year.
  • Income from Continuing Operations reached 6745000.0 in Q4 2025 per TMCI's latest filing, up from 16380000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 619000.0 in Q4 2024 to a low of 21318000.0 in Q2 2024.
  • Average Income from Continuing Operations over 5 years is 11055850.0, with a median of 12227000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: surged 90.29% in 2024, then crashed 989.66% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 6620000.0 in 2021, then surged by 38.75% to 4055000.0 in 2022, then tumbled by 57.26% to 6377000.0 in 2023, then soared by 90.29% to 619000.0 in 2024, then plummeted by 989.66% to 6745000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Income from Continuing Operations are 6745000.0 (Q4 2025), 16380000.0 (Q3 2025), and 17520000.0 (Q2 2025).